Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-008659
Filing Date
2011-02-14
Accepted
2011-02-14 19:26:21
Documents
4
Period of Report
2010-10-31

Document Format Files

Seq Description Document Type Size
1 v211438_10k.htm 10-K 562170
2 v211438_ex21.htm EX-21 2103
3 v211438_ex31-1.htm EX-31.1 14588
4 v211438_ex32-1.htm EX-32.1 9887
  Complete submission text file 0001144204-11-008659.txt   590240
Mailing Address 2670 TOWNE VILLAGE DRIVE DULUTH GA 30097
Business Address 2670 TOWNE VILLAGE DRIVE DULUTH GA 30097 678.428.6026
Cahaba Pharmaceuticals, Inc. (Filer) CIK: 0001476638 (see all company filings)

EIN.: 263439890 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 333-163172 | Film No.: 11611343
SIC: 7372 Services-Prepackaged Software